Walleye Trading
PBAXU

Walleye Trading’s Phoenix Biotech Acquisition Corp. Unit PBAXU Stock Holding History

Walleye Trading’s Portfolio PBAXU Stock Details PBAXU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-26,964
Closed -$272K – 5544
2022
Q3 		$272K Hold
26,964
– – ﹤0.01% 3438
2022
Q2 		$271K Hold
26,964
– – ﹤0.01% 3465
2022
Q1 		$271K Hold
26,964
– – ﹤0.01% 3524
2021
Q4 		$272K Buy
+26,964
New +$273K ﹤0.01% 3581

Other funds holding PBAXU

YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Walleye Trading's PBAXU Position: Q4 2022 in Review

Walleye Trading sold out of Phoenix Biotech Acquisition Corp. Unit (PBAXU) in Q4 2022, closing a stake of 26,964 shares — an estimated $272K sold.

Walleye Trading first reported a position in PBAXU in Q4 2021 and held it in 4 quarters. The position peaked at $272K in Q3 2022. 3 funds tracked by Wall St. Rank hold PBAXU as of Q4 2022.

  • Walleye Trading reported no remaining Phoenix Biotech Acquisition Corp. Unit position as of Q4 2022 after selling out during the quarter.
  • Walleye Trading sold 26,964 Phoenix Biotech Acquisition Corp. Unit shares in Q4 2022, an estimated $272K.
  • Walleye Trading first reported a position in Phoenix Biotech Acquisition Corp. Unit in Q4 2021 and held it in 4 quarters.
  • Walleye Trading's Phoenix Biotech Acquisition Corp. Unit position peaked at $272K in Q3 2022.
  • 3 funds tracked by Wall St. Rank held Phoenix Biotech Acquisition Corp. Unit as of Q4 2022.

Based on Walleye Trading's 13F filing for Q4 2022, filed 14 Feb 2023.